NetNoggin® releases exploratory analysis “Is TRIKAFTA a true ‘game changer’?”

FREDERICK, Md., Aug. 6, 2020 /PRNewswire/ — A new exploratory study, conducted by NetNoggin®, highlights patient and caregiver reported change in lung function, expectations, and lexicon for patients who have been on TRIKAFTA.

Marketing Director of NetNoggin®, Megan Newcomer, explains, “We’ve been tracking how TRIKAFTA has influenced the cystic fibrosis community in our new report, NetNog: #genesis® Cystic Fibrosis V2.0, but we wanted to release an exploratory study that analyzes if this market disruptor is truly perceived as a ‘game changer’ now that it has been on the market for more than nine months. We did an exploratory study shortly after TRIKAFTA was launched in October 2019, and saw the excitement and lexicon themes around TRIKAFTA being a ‘game changer.’ We thought it was appropriate now to look at TRIKAFTA again and compare the results to those we originally saw in October.”

The results of this exploratory analysis show that while TRIKAFTA met and even exceeded expectations for many patients, others were less satisfied by its effect. Visit https://netnoggin.net/exploratory-analysis to request the full exploratory analysis.

Additional results for TRIKAFTA’s disruption can be found in NetNoggin‘s syndicated, comprehensive report, NetNog: #genesis® Cystic Fibrosis V2.0, which includes updates to the patient journey due to TRIKAFTA, and puts the TRIKAFTA market disruption into context by highlighting the patient experience of those on TRIKAFTA as well as those not on TRIKAFTA.

For pricing of NetNog: #genesis® Cystic Fibrosis V2.0, contact Megan Newcomer at megan.newcomer@netnoggin.net.

About NetNoggin®
NetNoggin®, a subsidiary of Conger Consulting, LLC, is a premier market research agency that specializes in pharmaceutical marketing. NetNoggin® takes unstructured social data and structures it using their technology and expert personnel (netnographers) who are trained in various disease areas, linguistics, storytelling, pharmaceutical marketing, and science to ensure the context and interpretation of the data is accurate. By leveraging 30+ years of experience, their proprietary process derives strategic consulting insights from big data to inform Foundational Marketing Tools (FMTs), strategies, and tactics. NetNoggin® has expertise in market research; commercial, market, and clinical development; and communications to provide reliable research, presentations, and workshops.

NetNoggin® Media Relations

If you would like more information on this topic, please contact Megan Newcomer at megan.newcomer@netnoggin.net.

View original content to download multimedia:http://www.prnewswire.com/news-releases/netnoggin-releases-exploratory-analysis-is-trikafta-a-true-game-changer-301107830.html

SOURCE NetNoggin

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

11 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

12 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago